Christopher Hite - Net Worth and Insider Trading
Christopher Hite Net Worth
The estimated net worth of Christopher Hite is at least $2 Million dollars as of 2024-09-21. Christopher Hite is the EVP & Vice Chairman of Royalty Pharma PLC and owns about 70,000 shares of Royalty Pharma PLC (RPRX) stock worth over $2 Million. Details can be seen in Christopher Hite's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Hite has not made any transactions after 2020-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Hite
Christopher Hite Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Hite owns 2 companies in total, including Royalty Pharma PLC (RPRX) , and Acceleron Pharma Inc (XLRN) .
Click here to see the complete history of Christopher Hite’s form 4 insider trades.
Insider Ownership Summary of Christopher Hite
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2020-06-18 | EVP & Vice Chairman |
| XLRN | Acceleron Pharma Inc | 2020-06-04 | director |
Christopher Hite Latest Holdings Summary
Christopher Hite currently owns a total of 1 stock. Christopher Hite owns 70,000 shares of Royalty Pharma PLC (RPRX) as of June 18, 2020, with a value of $2 Million.
Latest Holdings of Christopher Hite
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2020-06-18 | 70,000 | 27.54 | 1,927,800 |
Holding Weightings of Christopher Hite
Christopher Hite Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Hite has made a total of 1 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Royalty Pharma PLC is the acquisition of 70,000 shares on June 18, 2020, which cost Christopher Hite around $2 Million.
Insider Trading History of Christopher Hite
- 1
Christopher Hite Trading Performance
GuruFocus tracks the stock performance after each of Christopher Hite's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Hite is -17.52%. GuruFocus also compares Christopher Hite's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Hite within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Hite's insider trading performs compared to the benchmark.
Performance of Christopher Hite
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.18 | | | | | |
| Relative Return to S&P 500(%) | -16.69 | | | | | |
Christopher Hite Ownership Network
Christopher Hite Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Christopher Hite is the EVP & Vice Chairman of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Christopher Hite made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net purchase of 600,000 shares made by Pablo G. Legorreta , a net sale of 2,359,950 shares made by Rory B Riggs , and a net sale of 934,197 shares made by Avara Management Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,749,147 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,149,147 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Christopher Hite Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Hite. You might contact Christopher Hite via mailing address: C/o Acceleron Pharma Inc., 128 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
